Anzeige
Mehr »
Lynx Broker
Login
Montag, 21.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YHA5 ISIN: US23283M1018 Ticker-Symbol: 296 
Stuttgart
18.10.19
19:19 Uhr
0,266 Euro
-0,030
-10,14 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CYTODYN INC Chart 1 Jahr
5-Tage-Chart
CYTODYN INC 5-Tage-Chart

Aktuelle News zur CYTODYN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
11.10.CytoDyn Inc.: CytoDyn to Present at The MicroCap Rodeo Conference1
CYTODYN Aktien jetzt im kostenlosen Demokonto handeln!
10.10.CEO of CytoDyn, Dr. Nader Pourhassan, Shares The Progress of The Company's Leronlimab Trials with The Stock Day Podcast250Phoenix, Arizona--(Newsfile Corp. - October 10, 2019) - The Stock Day Podcast welcomed CytoDyn Inc. (CYDY) ("the Company"), a biotechnology company developing innovative treatments for multiple therapeutic...
► Artikel lesen
08.10.CytoDyn Inc. - 10-Q, Quaterly Report1
03.10.CytoDyn Inc. - 8-K, Current Report1
02.10.NA Proactive news snapshot: Recruiter.com, Nerds On Site, Allot, Q BioMed, CytoDyn 3
02.10.CytoDyn wins FDA clearance to begin Phase 2 trial of its drug leronlimab in patients with NASH1
02.10.FDA OKs CytoDyn's mid-stage leronlimab trial2
02.10.CytoDyn Inc.: CytoDyn Announces FDA Clearance to Proceed with Phase 2 Clinical Trial of Leronlimab (PRO 140) for ...4
30.09.NA Proactive news snapshot:, CytoDyn, Nerds On Site, Auryn Resources, 1933 Industries …14
30.09.CytoDyn's triple-negative breast cancer drug leronlimab given to first patient in clinical trial1
28.09.CytoDyn Inc.: CytoDyn Treats First Patient in Phase 1b/2 Clinical Trial with Leronlimab (PRO 140) for Patients ...1
26.09.CytoDyn Inc.: CytoDyn to Hold Investment Community Conference Call on September 30, 2019-
24.09.CytoDyn's 13 Shots On Goal De-Risk Investment3
19.09.CytoDyn Inc. - 8-K, Current Report1
19.09.CytoDyn has multiple shots on goal with its flagship drug leronlimab as cure for HIV, various cancers4
17.09.CytoDyn: Passing PRO-140 Milestones While Generating More3
16.09.CytoDyn (CYDY) Investor Presentation - Slideshow2
13.09.CytoDyn Inc. - 8-K, Current Report-
09.09.NA Proactive news snapshot: Lydian International, CytoDyn, Pure Gold Mining, XPhyto Therapeutics UPDATE …11
09.09.CytoDyn on go with mid-stage study of PRO 140 in colorectal cancer2
Seite:  Weiter >>
114 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1